I'm LongbridgeAI, I can summarize articles.Arcutis Biotherapeutics EVP and Chief Legal Officer Masaru Matsuda sold 3,674 common shares on September 16, 2026, for a total of $91,753.31 at a weighted average price of $25 per share. Following the transaction, his direct holdings decreased to 112,508 shares.
- Masaru Matsuda, EVP and Chief Legal Officer at Arcutis Biotherapeutics, sold 3,674 common shares on Sept. 16, 2026. * Sale priced at a weighted average of $25 per share. * Direct holdings fell to 112,508 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-062732), on September 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here